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Abstract
Shiga toxin (Stx)-producing Escherichia coli (STEC) cause post-diarrhea Hemolytic Uremic Syndrome (HUS), which is the most
common cause of acute renal failure in children in many parts of the world. Several non-O157 STEC strains also produce
Subtilase cytotoxin (SubAB) that may contribute to HUS pathogenesis. The aim of the present work was to examine the
cytotoxic effects of SubAB on primary cultures of human cortical renal tubular epithelial cells (HRTEC) and compare its
effects with those produced by Shiga toxin type 2 (Stx2), in order to evaluate their contribution to renal injury in HUS. For
this purpose, cell viability, proliferation rate, and apoptosis were assayed on HRTEC incubated with SubAB and/or Stx2
toxins. SubAB significantly reduced cell viability and cell proliferation rate, as well as stimulating cell apoptosis in HRTEC
cultures in a time dependent manner. However, HRTEC cultures were significantly more sensitive to the cytotoxic effects of
Stx2 than those produced by SubAB. No synergism was observed when HRTEC were co-incubated with both SubAB and
Stx2. When HRTEC were incubated with the inactive SubAA272B toxin, results were similar to those in untreated control cells.
Similar stimulation of apoptosis was observed in Vero cells incubated with SubAB or/and Stx2, compared to HRTEC. In
conclusion, primary cultures of HRTEC are significantly sensitive to the cytotoxic effects of SubAB, although, in a lesser
extent compared to Stx2.
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Introduction
Shiga toxin (Stx)-producing Escherichia coli (STEC) colonizes the
distal small intestine and colon causing watery diarrhea, hemor-
rhagic colitis, and hemolytic uremic syndrome (HUS) [1,2]. HUS
is the most common cause of acute renal failure in children in
many parts of the world and the second leading cause of chronic
renal failure in children younger than 5 years [2,3]. Renal
damages have been strongly associated with Shiga toxin type 1
and/or 2 (Stx1, Stx2) [4] produced by Escherichia coli O157:H7 and
other related strains frequently isolated from children with HUS,
although strains expressing Stx2 are highly prevalent in Argentina
[5].
While the production of Stx by STEC is the primary virulence
factor responsible for HUS, it was reported that some STEC non-
O157 strains produce an additional toxin termed subtilase
cytotoxin (SubAB) which may play a role in the pathogenesis of
HUS [6,7]. SubAB was identified for the first time in a virulent
O113:H21 STEC strain that caused an outbreak of HUS in South
Australia [8]. The presence of subAB genes was further detected in
other STEC strains belonging to different serotypes, and in other
countries [7,9]. Recently, it was reported [9] the detection of subAB
gene in 36% of the cattle strains, and in 32% of human strains of
STEC strains isolated in Argentina.
Stx and SubAB cytotoxins are members of two different AB5
toxin families, which contain an A subunit monomer, of 32 kDa
and 35 kDa respectively, bound non-covalently to a pentamer of
7.7-kDa and 13-kDa B subunits respectively [6,10]. However, both
toxins bind to different membrane receptors and exert their
cytotoxic activity through different cell pathways.
The Stx B subunit pentamer binds to the glycolipid globo-
triaosylceramide (Gb3) on the plasma membrane of target cells
[11], followed by holotoxin internalization into the cell and
transport to the endoplasmic reticulum by a retrograde pathway
[12]. Stx A-subunit is cleaved by a furin-like protease, releasing the
enzymatically active A1-subunit, which is translocated into the
cytoplasm where it exhibits RNA N-glycohydrolase activity and
cleaves a specific adenine residue on the 28S ribosomal RNA in
the cytosol, thereby inhibiting protein synthesis [13,14]. The
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binding of Stx to renal tubular epithelial cells expressing Gb3 in
vitro [15,16] and in vivo [15,17–19] has been shown to decrease cell
viability, inhibit protein synthesis and induce apoptosis and
necrosis. We have previously observed that C-9 (Genzyme,
Waltham, MA), a specific inhibitor of glucosylceramide (GL1)
synthase, decreases Gb3 expression levels and prevents the
cytotoxic effects of Stx2 on primary cultures of human renal
tubular epithelial cells (HRTEC) (20). In Sprague-Dawley rats
intraperitoneally injected with a filtered bacterial supernatant
containing Stx2, oral treatment with C-9 significantly decreased
mortality to 50% and reduced the extent of renal and intestinal
injuries in the surviving animals [19].
The B subunit pentamer of SubAB binds to the surface of target
cells via glycans displayed on glycoproteins [21] that terminate in
a2-3-linked N-glycolylneuraminic acid (Neu5Gc) [22]. The A
subunit, is a subtilase-like serine protease that selectively cleaves
the endoplasmic reticulum (ER) chaperone glucose-regulated
protein 78 (GRP78, also known as BiP) [23], triggering ER stress
signaling pathways and the unfolded protein response (UPR) [24].
This leads to transient inhibition of protein synthesis and cell cycle
arrest at G1 phase, and induces caspase-dependent apoptosis via
mitochondrial membrane damage in Vero cells and HeLa cells
[24–27]. Serine protease activity is fundamental to the cytotoxic
mechanism of SubAB. Mutation of Ser272RAla in the A subunit
of SubAB completely eliminated serine protease activity and cell
cytotoxicity [6]. Studies in vivo showed that SubAB caused HUS-
like pathologies, which are associated with induction of apoptosis
in the liver, kidney and spleen [6,28].
The purpose of the present work was to study the cytotoxic
effects of SubAB on primary cultures of human cortical renal
tubular epithelial cells (HRTEC). SubAB studies were performed
in parallel with those of Stx2 in order to evaluate and compare
their contribution on the renal tubular injury in HUS.
Materials and Methods
Reagents
Toxins: Stx2 was purchased at Phoenix Laboratory, Tufts
Medical Center, Boston, MA, USA and it was checked for
lipopolysaccharide (LPS) contamination by Limulus amoebocyte
lysate assay. Stx2 contained ,10 pg LPS/ng of pure Stx2. The
SubAB and the inactive mutant SubAA272B were purified as
described previously [6,23].
Cell culture
HRTEC primary cultures were isolated from kidneys removed
from pediatric patients undergoing nephrectomies, at the ‘‘Servi-
cio de Pediatrı´a, Hospital Nacional Prof. A. Posadas’’, Buenos
Aires, Argentina. Written informed consent from the next of kin,
or guardians on the behalf of the children was obtained for use of
these samples for research. The Ethics Committee of the Hospital
Nacional Prof. A. Posadas approved the use of human renal tissues
for research purposes. The cortex was dissected from the renal
medulla and the primary cultures were performed according to the
methods described previously [29]. The cortical fragments were
incubated for 30 min at 37uC in Hank’s solution containing 0.1%
collagenase type I. Then, the preparation was washed and filtered
through a 70 mm pore size cell strainer (BD Bioscience, MA,
USA), to discard the glomeruli. The filtered tubules were
incubated in Hank’s solution containing 0.2% collagenase type 1
(Sigma-Aldrich, St Louis, MO, USA), for 30 min at 37uC. The
obtained cells were washed and resuspended in RPMI 1640
medium (HyClone) supplemented with 5% fetal bovine serum
(FBS), 2 mM L-glutamine and 100 U/ml penicillin/streptomycin
(all from GIBCO BRL, Grand Island, NY, USA). Cells were
incubated in 5% CO2 atmosphere at 37uC and grown in flasks to
confluence. Cells were cultured in flasks in RPMI medium with
supplements and 1% endothelial cell growth supplement (Sigma),
and used between 3–5 passages. By light microscopy, more than
95% of the cells had similar morphologies. These cells were
confirmed as epithelial cells by positive staining for cytokeratins.
These cells were also positive stained for aquaporin 1 (Anti-AQP1,
Alpha Diagnostic, USA), confirming their origin as proximal
tubule epithelial cells. Furthermore, the cells were also negative for
the endothelial cell antigen CD31. Depending on the particular
experiment, HRTEC cells were grown in 96-well plates, or in glass
cover slips in 24-well plates.
For some experiments, the Vero cell line was also cultured in
flasks in RPMI 1640 medium supplemented with 10% FBS, 2 mM
L-glutamine and 100 U/ml penicillin/streptomycin.
Neutral red cytotoxicity assay
The neutral red cytotoxicity assay was performed according to
the method described previously [29]. HRTEC cells were plated
in 96-well plates and grown to sub-confluence in complete RPMI
medium. Cells were then washed and exposed to different
dilutions of SubAB, SubAA272B, or Stx2 under growth-arrested
conditions (endothelial growth supplement and serum free-
medium) for 24 and 72 h. Two hundred microliters of freshly
diluted neutral red in RPMI medium were then added to a final
concentration of 50 mg/ml and cells were incubated for an
additional 3 h at 37uC in 5% CO2. Cells were then washed with
1% CaCl2 and 4% formaldehyde, and solubilized in 1% acetic
acid and 50% ethanol. Absorption in each well was read in an
automated plate spectrophotometer at 546 nm. Results are
expressed as neutral red uptake percent, with 100% representing
cells incubated under identical conditions but without toxin
treatment.
Apoptosis
Acridine orange (AO) - ethidium bromide (EB): Apoptosis was
analyzed on HRTEC and Vero cells cultured on cover slips for
2 days, immersed in 24-well plates with RPMI medium with
supplements. Cells were incubated for 1 h–24 h with 10 ng/ml of
SubAB and/or 10 ng/ml of Stx2, in growth arrest conditions. For
some experiments cells were incubated with the mutated toxin
SubAA272B (10 ng/ml). After each treatment, the percentage of
apoptotic cells was established morphologically by fluorescence
microscopy after staining with acridine orange/ethidium bromide
(1:1, v/v) in a final concentration of 100 mg/ml [30]. Each
experiment was performed in duplicate, counting a minimum of
200 total cells per duplicate. The fluorescence was observed with a
Nikon model Eclipse E-2000 fluorescence microscope. Images
were captured with a digital camera (Nikon E4300) and processed
using the Adobe Photoshop 6.0 image analysis software package
(Media Cybernetics). Apoptotic cells were defined on the basis of
nuclear morphologic changes such as chromatin condensation and
staining [30]. Normal cells are permeable to AO but impermeable
to EB, while apoptotic and necrotic cells become permeable also to
EB. Therefore, live cells show normal coloration of the nuclei, with
green chromatin and organized structures; apoptotic cells present
chromatin condensation and fragmentation, and a green-yellow or
orange coloration, and necrotic cells have similar normal nuclei
staining as live cells except the chromatin is red-orange instead of
green.
Annexin V-FITC – Propidium Iodide (AV-PI): Apoptosis was also
analyzed by AV-PI staining, using the apoptosis detection kit
supplied by Sigma-Aldrich. HRTEC cells were cultured on cover
Human Renal Cells Are Sensitive to Subtilase
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slips for 2 days, immersed in 24-well plates with RPMI medium
with supplements, as described above. Cells were incubated with
SubAB and/or Stx2 for 24 h. Cells were then incubated with a
solution of annexin V-FITC and propidium iodide (1:1 v/v; 2 ug/
ml) for 10 min at room temperature. Annexin V-FITC and
propidium iodide were detected as green and red fluorescence,
respectively, under a fluorescence microscope, as was described
elsewhere [31]. Constant optical threshold and filter combination
were used. To calculate the percentage of apoptotic and necrotic
cells, each experiment was done in duplicate and a minimum of
200 total cells were evaluated per duplicate. Live cells showed no
staining by either PI or AV. Cells which were early in the
apoptotic process stained with the AV alone. Late apoptotic cells
were stained by both AV and PI, while necrotic cells were stained
by PI alone.
Cell proliferation
Cell proliferation rate was measured at different times by
incorporation of bromodeoxyUridine (5-Bromo-2-DeoxyUridine,
BrdU) into the DNA of cells in S-phase of the cell cycle, and
detected using a specific antibody. HRTEC cultures grown on
cover slips were incubated with 10 ng/ml of SubAB, SubAA272B,
or Stx2, for 2 to 24 h. After treatments, cells were pulse-labeled
with 10 mM BrdU (Sigma-Aldrich, St Louis, MO, USA) for 2 h at
37uC. Cells were then fixed with 70% ethanol, denatured with 2N
HCl and 0.5% triton X-100, and neutralized with 0.1 M
Na2B4O7, pH: 8.5. For BrdU detection, indirect immunofluores-
cence was performed using an antibody against BrdU (Sigma-
Aldrich) diluted 1:100 in PBS with 5% FBS, and 0.05% Tween 20.
Alexa fluor 488 goat anti-mouse IgG (Invitrogen) diluted 1:200 in
PBS was used as secondary antibody.
Statistical analysis
Results are reported as means 6 standard error of the mean
(SEM). The significance of any differences was determined using




The cytotoxic activity of SubAB and Stx2 was evaluated on
HRTEC by the measurement of cell viability using the neutral red
uptake assay. For this purpose, confluent HRTEC were incubated
with different dilutions of SubAB and Stx2, for 24 h and 72 h.
Both SubAB and Stx2 inhibited cell viability in a time- and dose-
dependent manner (Figure 1). Incubation with 100 ng/ml of
Stx2 or SubAB for 24 h produced a significant reduction in cell
viability (Figure 1A). No potentiation of the cytotoxic effect was
observed when cells were co-incubated with different concentra-
tions of both SubAB and Stx2 toxins at different times (Figure 1A
and 1B). Incubation with 0.01 ng/ml of Stx2 for 72 h produced a
50% of inhibition of HRTEC viability, whereas SubAB caused an
approximately 50% of inhibition in the concentration range of 1–
100 ng/ml (Figure 1B). As shown in Figure 1B, Stx2 produced
a significantly higher inhibition of cell viability than SubAB at
concentrations equal to or greater than 0.01 ng/ml, while no
significant differences were observed between the two toxins when
HRTEC were exposed at doses less than or equal to 0.001 ng/ml.
Incubation with the non-toxic mutant SubAA272B (100 ng/ml) for
24 or 72 h did not affect HRTEC viability (Figure 1C).
Figure 1. Effect of SubAB and Stx2 on cell viability by neutral
red uptake assay. Both SubAB and Stx2 inhibited HRTEC viability in a
dose dependent manner at 24 h (A) and 72 h (B). No potentiation of
the cytotoxic effect was observed when cells were co-incubated with
SubAB and Stx2, for 24 h (A). HRTEC viability was not significantly
modified by the incubations with SubAA272B (100 ng/ml) for 24 or 72 h
(C). Results are expressed as neutral red uptake percent, where 100%
represents control cells without toxin treatment. Each point represents
the mean 6 SEM of three to five experiments. Student’s t-tests indicate
significant differences *p,0.05, for SubAB vs Stx2 treatments, and
#p,0.05, for SubAB and/or Stx2 treated vs untreated control cells.
doi:10.1371/journal.pone.0087022.g001
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Apoptosis
To perform HRTEC proliferation rate and apoptosis assays at
24 h and earlier times, a dose of SubAB that killed about 50% of
HRTEC in 72 h (10 ng/ml) was chosen. Apoptotic cells were
detected by morphological appearance of the cells stained with
AO-BE (Figure 2A) and by AV-PI staining (Figure 2B).
Figure 2C shows apoptosis assessed by AO-BE staining of
HRTEC cultures exposed to SubAB or Stx2 (10 ng/ml, each), at
different times. As well as effects on cell viability, both toxins
stimulated the percentage of apoptotic cells in a time dependent
manner, although Stx2 produced a significantly higher stimulation
of apoptosis than SubAB on HRTEC primary cultures at
equivalent doses (Figure 2C). A significant stimulation of the
percentage of apoptotic cells was detected first after 4 h incubation
with Stx2, and 24 h incubation with SubAB (Figure 2C).
However, 24 h co-incubation with both toxins (Figure 2D) did
Figure 2. Percentage of apoptosis in HRTEC primary cultures and Vero cells exposed to SubAB and/or Stx2. Apoptosis was evaluated
by acridine orange-ethidium bromide (AO-BE) staining (A, C, and D), and Annexin V-FITC - Propidium Iodide (AV-IP) (B and E) assays. Detection of
apoptosis by AO/EB assay (A): live cells (a) show normal coloration of the nuclei, with green chromatin and organized structures; apoptotic cells
present chromatin condensation and fragmentation (b, white arrows). Detection of apoptosis by AV-IP assay (B): early and late apoptotic cells were
stained by AV (green) alone and by both AV and IP (green and red), respectively; while necrotic cells were stained by IP (red) alone. Bars in A and B:
50 mm. Exposure to SubAB or Stx2 (10 ng/ml each) induced apoptosis in HRTEC in a time dependent manner (C). Co-incubation with Stx2 and SubAB
for 24 h did not potentiate the apoptosis and necrosis in HRTEC (D, E), nor in Vero (D) cultures. Each bar represents the mean 6 SEM of three to five
independent experiments. Student’s t-tests indicate significant differences (*p,0.05 and **p,0.01) for SubAB and/or Stx2 treated vs untreated
control cells.
doi:10.1371/journal.pone.0087022.g002
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not potentiate the apoptosis in HRTEC primary cultures nor in
the Vero cell line. Moreover, higher stimulation of apoptosis was
also observed in Vero cells exposed to Stx2, than in SubAB-treated
cells (Figure 2D).
To analyze apoptosis and necrosis, the incorporation of AV-PI
(Figure 2E and 2B) in HRTEC cultures exposed to SubAB and
Stx2 was also examined, corroborating the results of apoptosis
obtained using the AO-BE assay. As shown in Figure 2E,
incubation with 10 ng/ml SubAB for 24 h significantly stimulated
HRTEC apoptosis compared to control cells (% Apoptosis:
1861.9 vs. 3.761.8, respectively, p,0.05). Furthermore, a higher
percentage of apoptotic cells (3465%) was observed in HRTEC
exposed to the same dose of Stx2 (Figure 2E). Stx2 also produced
a small but significant increase in the percentage of necrotic cells,
while SubAB did not induce necrosis in HRTEC cultures
(Figure 2E). Co-incubation with SubAB and Stx2 for 24 h did
not potentiate their apoptotic or necrotic effects on HRTEC,
similarly to the results shown for cell viability (Figure 1A and 1B)
and apoptosis by AO-BE (Figure 2D and 2E).
In agreement with the results for cell viability above, incubation
with the mutated SubAA272B did not stimulate HRTEC apoptosis
compared to non-treated cells (Figure 2C and 2E).
Cell proliferation rate
Cell proliferation rate was measured by BrdU uptake in
HRTEC, allowing determination of the DNA replication rate.
Control HRTEC cultures grown in RPMI medium supplemented
with endothelial cell growth supplement and 5% FBS, showed
about 30 to 36% BrdU positive cells. As shown in Figure 3A,
incubation with 10 ng/ml of either Stx2 or SubAB produced a
significant inhibition of cell proliferation with respect to untreated
control cells, in a time-dependent manner. However, Stx2
produced a significantly higher inhibition of cell proliferation
compared to SubAB at all times studied. When HRTEC were
incubated with Stx2 or SubAB for 2 h followed by pulse-labeling
with BrdU for another 2 h, cell proliferation was reduced to about
25% and 60%, respectively, relative to untreated control cells.
Moreover, cell proliferation was completely inhibited after 6 h
exposure to Stx2, while residual proliferation remained after 24 h
incubation with SubAB (Figure 3A). These results are consistent
with those observed for cell viability and apoptosis, confirming that
HRTEC were more sensitive to Stx2 than SubAB cytotoxic effects.
Incubation with 10 ng/ml of SubAA272B did not modify BrdU
uptake by HRTEC cultures (Figure 3B).
Discussion
In previous studies, SubAB toxin was found to be lethal for
mice, resulting in extensive microvascular damage, thrombosis and
necrosis in several organs, including the kidneys [6,28], features
observed in Stx-induced HUS in humans. The holotoxin was also
proved to be highly toxic for several cell lines, including Vero cells
[6,23–27]. However, the role that SubAB plays in the pathogenesis
of HUS remains to be elucidated. Production of SubAB or
presence of the subAB genes has been detected in numerous STEC
serotypes [7,9], many of which have been associated with HUS
cases around the world. All of these STEC strains lacked the locus
of enterocyte effacement (i.e. they were LEE-negative) and, with
the exception of one recent report [32] all strains produced SubAB
as well as Stx1 and/or Stx2 [7,9]. The role of Stx has been studied
extensively in several animal models with the aim of demonstrating
its role in the pathophysiology of HUS [15,18,19,33–35].
Numerous studies in different cell types have also been performed
to elucidate the mechanisms by which Stxs exert their effects on
protein synthesis inhibition, and stimulation of cell apoptosis and
necrosis [15,16,29,36].
In the present work, we have studied the cytotoxic effects of
SubAB on HRTEC, a primary culture of human renal proximal
tubular epithelial cells. Treatments with SubAB were conducted in
parallel with those performed with Stx2 under identical conditions,
to compare the effects produced by the two toxins on HRTEC,
and to investigate whether the effects of one toxin may influence
the effects of the other. Here, we show for the first time that
SubAB significantly inhibited cell viability and cell proliferation
rate, as well as stimulating apoptosis in HRTEC cultures,
demonstrating a significant sensitivity to SubAB cytotoxin.
However, HRTEC cultures were significantly more sensitive to
the cytotoxic effects of Stx2 than those induced by SubAB.
Apoptosis assays were also performed in Vero cells, which showed
Figure 3. Cell proliferation rate measured by bromodeoxyur-
idine (BrdU) uptake in HRTEC primary cultures. HRTEC were
incubated with 10 ng/ml of either Stx2 or SubAB for different times (A).
Both toxins produced a significant inhibition on the percentage of cell
proliferation, compared to untreated control cells, in a time dependent
manner, although HRTEC were more sensitive to Stx2 than SubAB. (A).
Incubation with 10 ng/ml of SubAA272B did not modify BrdU uptake of
HRTEC relative to untreated control cells (B). Each bar represents the
mean 6 SEM of three different experiments. Student’s t-tests indicate
significant differences (*p,0.05 and **p,0.01) for SubAB vs Stx2
treated cells and for SubAB or Stx2 treated vs untreated control cells
(##p,0.01).
doi:10.1371/journal.pone.0087022.g003
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results comparable to those obtained in the primary HRTEC
cultures. Furthermore, about 20% of cells in HRTEC cultures
remain alive after 72 h of Stx2 exposure indicating that a
subpopulation of HRTEC is relatively toxin resistant. Similar
results were reported in HK-2 cells [37].
Taking account of the fact that serine protease activity is central
to the mechanism of action of SubAB [6], non-proteolytic mutant
SubAA272B was used as a negative control. Incubation of HRTEC
with SubAA272B showed similar results to those for untreated
control cells, confirming the specific effects produced by SubAB.
Furthermore, it was previously demonstrated that pretreatment
with C-9, a specific inhibitor of glucosylceramide synthase,
inhibited the biosynthesis of Gb3 in HRTEC [20] and in rat
kidneys in vivo [19], and neutralized the cytotoxic effects of Stx2
[19,20]. These results showed that the sensitivity of HRTEC to
Stx2 is dependent on the presence of the receptor Gb3 on their
surface. In contrast, SubAB binds with a very high degree of
specificity to cell surface glycans terminating in a2-3-linked
Neu5Gc [22]. Although humans are genetically unable to produce
the sialic acid Neu5Gc, it was demonstrated that Neu5Gc is taken
up from the diet and assimilated into several human tissues,
including the renal tubular epithelium [38]. Therefore, our results
suggest the presence of Neu5Gc in HRTEC.
Interestingly, no synergism was observed when HRTEC were
co-incubated with both Stx2 and SubAB in any of our studies.
Experiments carried out with Stx2 alone produced similar
cytotoxic effects to those in which cells were co-treated with both
Stx2 and SubAB toxins. These results are consistent with those
recently reported by Amaral et al. [39], where no evidence of
synergy was observed in human renal microvascular endothelial
cells treated with a combination of SubAB and Stx2.
Although HRTEC primary cultures were highly sensitive to
SubAB and Stx2 toxins, differences between their cytotoxic
activities were observed. To analyze these mechanisms, we studied
necrosis and apoptosis of HRTEC exposed to Stx2 and SubAB.
Both toxins caused significantly more apoptosis than necrosis.
While Stx2 increased apoptosis in a time-dependent manner as
early as 4 h after treatment, SubAB caused apoptosis only after
24 h of treatment. Faster effects on cell proliferation were also
observed in HRTEC exposed to Stx2 than in cells treated with
SubAB. Differences in intracellular trafficking may play a role in
susceptibility to toxin-mediated cytotoxicity. It is known that
efficient retrograde transport of the toxin is necessary for Stx
cytotoxic effects [12,40]. In most cell types, the induction of
apoptosis requires transport of enzymatically active Stx to the
endoplasmic reticulum (ER) and activation of the ribotoxic stress
response or induction of the UPR [37,41–43]. It was established
that like Stx, SubAB is also trafficked from the cell surface via the
Golgi to the ER via a retrograde pathway. However, SubAB uses a
distinct route through the Golgi [44], and its internalization and
trafficking is exclusively clathrin-dependent [45], whereas Stx can
also exploit the lipid raft transport pathway. Once in the ER
lumen, SubAB cleaves GRP78 and induces ER stress and the
UPR [23,24]. Therefore, both Stx and SubAB may induce
apoptosis through prolonged activation of the ER stress response.
This mechanistic overlap, together with the possibility that Stx2
quikly achieve apoptotic machinery in HRTEC, masking the
action of SubAB, may explain the lack of synergy between the two
toxins.
Both SubAB and Stx2 significantly inhibited HRTEC prolifer-
ation, measured as BrdU uptake into the DNA, although SubAB
caused a lesser effect than Stx2. It has been reported that
interference with the cell cycle, which results in inhibition of cell
proliferation and activation of cell cycle checkpoints, is often
associated with the initiation of apoptosis [46]. It has been
demonstrated that incubation of human HCT116 colon cancer
cells with Stx1 induced the arrest of cells in S phase, followed by
programmed cell death [47]. Other studies showed that Stx1
activated the ATM/p53-dependent DNA damage signaling
pathway and induced apoptosis [48]. SubAB toxin was also
demonstrated to induce cell cycle arrest in G1 phase, possibly
through down-regulation of cyclin D1 due to a combination of
translational inhibition and proteasomal degradation [26]. There-
fore, the differential capacity of Stx2 and SubAB to inhibit
HRTEC proliferation may be related to the different ability to
cause apoptosis. However, the precise cytotoxic mechanisms
implemented by both SubAB and Stx2 toxins are still under study.
In conclusion, the present work shows that primary cultures of
human renal tubular epithelial cells are sensitive to the cytotoxic
effects of SubAB. The action of Stx2 is predominant on SubAB
activity, indicating that SubAB mechanisms could be masked by
Stx2 in HRTEC. Further studies will be necessary to understand
the mechanisms triggering in human host cells in response to the
combined action of SubAB cytotoxin and Stx2 produced by
STEC.
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